Related content

P-glycoprotein silencing with siRNA delivered by DOPE-modified PEI overcomes doxorubicin resistance in breast cancer cells

By Navarro Gemma   Sawant Rupa R   Biswas Swati   Essex Sean   Tros de Ilarduya Conchita   Torchilin Vladimir P  

Nanomedicine, Vol. 7, Iss. 1, 2012-01 ,pp. : 65-78

Future Medicine

Access to resources Recommend Favorite

N-lauroyl chitosan surface-modified PLGA nanoparticles as carrier for adriamycin to overcome cancer drug resistance

By Li Jing   Zhou Ping   Wang Yan   Chen Hongli   Zhang Cong   Li Rongshan   Yang Xiaoying   Wang Yinsong  

Journal of Microencapsulation, Vol. 31, Iss. 3, 2014-05 ,pp. : 203-210

Informa Healthcare

Access to resources Recommend Favorite

Intrinsic resistance to chemotherapy in breast cancer

By Moulder Stacy  

Women's Health, Vol. 6, Iss. 6, 2010-11 ,pp. : 821-830

Future Medicine

Access to resources Recommend Favorite

Recent Developments in Targeting Breast Cancer Stem Cells

By  

Recent Patents on Regenerative Medicine, Vol. 1, Iss. 1, 2011-01 ,pp. : 1-18

Bentham Science Publishers

Access to resources Recommend Favorite

Enhanced binding and killing of target tumor cells by drug-loaded liposomes modified with tumor-specific phage fusion coat protein

By Wang Tao   D’Souza Gerard GM   Bedi Deepa   Fagbohun Olusegun A   Potturi L Prasanna   Papahadjopoulos-Sternberg Brigitte   Petrenko Valery A   Torchilin Vladimir P  

Nanomedicine, Vol. 5, Iss. 4, 2010-06 ,pp. : 563-574

Future Medicine

Access to resources Recommend Favorite